Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FRANK C WALDROP

Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery

NPI
1275624090
CMS profile
57321
Location
FRESNO, CA

General Payments · PY2018–2024

$1,306.00

  • Reported across 75 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$315.31

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $315.31 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $183.69 8
ABBVIE INC. $108.52 7
REVANCE THERAPEUTICS, INC. $23.10 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $69.37 5
PY2019 $68.85 5
PY2020 $125.09 10
PY2021 $84.92 5
PY2022 $170.80 12
PY2023 $471.66 22
PY2024 $315.31 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.83 02/01/2024 Food and Beverage Undisputed 01/23/2026 1106298103 CMS
ABBVIE INC. $14.36 03/26/2024 Food and Beverage Undisputed 01/23/2026 1106298105 CMS
ABBVIE INC. $15.48 04/23/2024 Food and Beverage Undisputed 01/23/2026 1106298107 CMS
ABBVIE INC. $15.82 06/20/2024 Food and Beverage Undisputed 01/23/2026 1106298109 CMS
ABBVIE INC. $18.01 07/31/2024 Food and Beverage Undisputed 01/23/2026 1106298111 CMS
ABBVIE INC. $14.23 10/24/2024 Food and Beverage Undisputed 01/23/2026 1106298113 CMS
ABBVIE INC. $16.79 12/10/2024 Food and Beverage Undisputed 01/23/2026 1106298115 CMS
Amgen Inc. $6.14 01/18/2024 Food and Beverage Undisputed 01/23/2026 1111735237 CMS
Amgen Inc. $26.97 03/05/2024 Food and Beverage Undisputed 01/23/2026 1111735239 CMS
Amgen Inc. $25.13 04/11/2024 Food and Beverage Undisputed 01/23/2026 1111735241 CMS
Amgen Inc. $23.65 05/20/2024 Food and Beverage Undisputed 01/23/2026 1111735243 CMS
Amgen Inc. $27.00 06/27/2024 Food and Beverage Undisputed 01/23/2026 1111735245 CMS
Amgen Inc. $26.45 08/15/2024 Food and Beverage Undisputed 01/23/2026 1111735247 CMS
Amgen Inc. $25.11 10/03/2024 Food and Beverage Undisputed 01/23/2026 1111735249 CMS
Amgen Inc. $23.24 12/03/2024 Food and Beverage Undisputed 01/23/2026 1111735251 CMS
REVANCE THERAPEUTICS, INC. $23.10 02/29/2024 Food and Beverage Undisputed 01/23/2026 1147931427 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.